219 related articles for article (PubMed ID: 28600026)
1. MetabolitePredict: A de novo human metabolomics prediction system and its applications in rheumatoid arthritis.
Wang Q; Xu R
J Biomed Inform; 2017 Jul; 71():222-228. PubMed ID: 28600026
[TBL] [Abstract][Full Text] [Related]
2. Combining mechanism-based prediction with patient-based profiling for psoriasis metabolomics biomarker discovery.
Wang Q; McCormick TS; Ward NL; Cooper KD; Conic R; Xu R
AMIA Annu Symp Proc; 2017; 2017():1734-1743. PubMed ID: 29854244
[TBL] [Abstract][Full Text] [Related]
3. Data-driven multiple-level analysis of gut-microbiome-immune-joint interactions in rheumatoid arthritis.
Wang Q; Xu R
BMC Genomics; 2019 Feb; 20(1):124. PubMed ID: 30744546
[TBL] [Abstract][Full Text] [Related]
4. Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activity.
Hur B; Gupta VK; Huang H; Wright KA; Warrington KJ; Taneja V; Davis JM; Sung J
Arthritis Res Ther; 2021 Jun; 23(1):164. PubMed ID: 34103083
[TBL] [Abstract][Full Text] [Related]
5. Serum metabolomic profiling predicts synovial gene expression in rheumatoid arthritis.
Narasimhan R; Coras R; Rosenthal SB; Sweeney SR; Lodi A; Tiziani S; Boyle D; Kavanaugh A; Guma M
Arthritis Res Ther; 2018 Aug; 20(1):164. PubMed ID: 30075744
[TBL] [Abstract][Full Text] [Related]
6. LC-MS-based serum metabolomics reveals a distinctive signature in patients with rheumatoid arthritis.
Li J; Che N; Xu L; Zhang Q; Wang Q; Tan W; Zhang M
Clin Rheumatol; 2018 Jun; 37(6):1493-1502. PubMed ID: 29442259
[TBL] [Abstract][Full Text] [Related]
7. Global metabolomic profiling of human synovial fluid for rheumatoid arthritis biomarkers.
Carlson AK; Rawle RA; Wallace CW; Adams E; Greenwood MC; Bothner B; June RK
Clin Exp Rheumatol; 2019; 37(3):393-399. PubMed ID: 30620276
[TBL] [Abstract][Full Text] [Related]
8. Biomarker identification and pathway analysis of rheumatoid arthritis based on metabolomics in combination with ingenuity pathway analysis.
He Z; Liu Z; Gong L
Proteomics; 2021 Jun; 21(11-12):e2100037. PubMed ID: 33969925
[TBL] [Abstract][Full Text] [Related]
9. Application of (1)H NMR-based serum metabolomic studies for monitoring female patients with rheumatoid arthritis.
Zabek A; Swierkot J; Malak A; Zawadzka I; Deja S; Bogunia-Kubik K; Mlynarz P
J Pharm Biomed Anal; 2016 Jan; 117():544-50. PubMed ID: 26476882
[TBL] [Abstract][Full Text] [Related]
10. A genomics-based systems approach towards drug repositioning for rheumatoid arthritis.
Xu R; Wang Q
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):518. PubMed ID: 27557330
[TBL] [Abstract][Full Text] [Related]
11. Large Scale Metabolic Profiling identifies Novel Steroids linked to Rheumatoid Arthritis.
Yousri NA; Bayoumy K; Elhaq WG; Mohney RP; Emadi SA; Hammoudeh M; Halabi H; Masri B; Badsha H; Uthman I; Plenge R; Saxena R; Suhre K; Arayssi T
Sci Rep; 2017 Aug; 7(1):9137. PubMed ID: 28831053
[TBL] [Abstract][Full Text] [Related]
12. Urine metabolome profiling of immune-mediated inflammatory diseases.
Alonso A; Julià A; Vinaixa M; Domènech E; Fernández-Nebro A; Cañete JD; Ferrándiz C; Tornero J; Gisbert JP; Nos P; Casbas AG; Puig L; González-Álvaro I; Pinto-Tasende JA; Blanco R; Rodríguez MA; Beltran A; Correig X; Marsal S;
BMC Med; 2016 Sep; 14(1):133. PubMed ID: 27609333
[TBL] [Abstract][Full Text] [Related]
13. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis.
Chen J; Wright K; Davis JM; Jeraldo P; Marietta EV; Murray J; Nelson H; Matteson EL; Taneja V
Genome Med; 2016 Apr; 8(1):43. PubMed ID: 27102666
[TBL] [Abstract][Full Text] [Related]
14. A systems biology approach to predict and characterize human gut microbial metabolites in colorectal cancer.
Wang Q; Li L; Xu R
Sci Rep; 2018 Apr; 8(1):6225. PubMed ID: 29670137
[TBL] [Abstract][Full Text] [Related]
15. Metabolite and Lipid Profiling of Biobank Plasma Samples Collected Prior to Onset of Rheumatoid Arthritis.
Surowiec I; Ärlestig L; Rantapää-Dahlqvist S; Trygg J
PLoS One; 2016; 11(10):e0164196. PubMed ID: 27755546
[TBL] [Abstract][Full Text] [Related]
16. Metabolomics in rheumatoid arthritis: Advances and review.
Xu L; Chang C; Jiang P; Wei K; Zhang R; Jin Y; Zhao J; Xu L; Shi Y; Guo S; He D
Front Immunol; 2022; 13():961708. PubMed ID: 36032122
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of targeted metabolomics: dominance-based rough set approach versus orthogonal partial least square-discriminant analysis.
Blasco H; Błaszczyński J; Billaut JC; Nadal-Desbarats L; Pradat PF; Devos D; Moreau C; Andres CR; Emond P; Corcia P; Słowiński R
J Biomed Inform; 2015 Feb; 53():291-9. PubMed ID: 25499899
[TBL] [Abstract][Full Text] [Related]
18. Serum metabolomic and lipidomic profiling identifies diagnostic biomarkers for seropositive and seronegative rheumatoid arthritis patients.
Luan H; Gu W; Li H; Wang Z; Lu L; Ke M; Lu J; Chen W; Lan Z; Xiao Y; Xu J; Zhang Y; Cai Z; Liu S; Zhang W
J Transl Med; 2021 Dec; 19(1):500. PubMed ID: 34876179
[TBL] [Abstract][Full Text] [Related]
19. Genomics, proteomics and metabolomics: their emerging roles in the discovery and validation of rheumatoid arthritis biomarkers.
Castro-Santos P; Laborde CM; Díaz-Peña R
Clin Exp Rheumatol; 2015; 33(2):279-86. PubMed ID: 25572119
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
